Market News How it works Learn FAQ
| AXG 0.0356 -33.83% | SHFS 0.1189 26.49% | DVLT 0.0681 -48.72% | XXII 0.1049 18.67% | NEXR 0.5784 29.14% | SOFI 16.4185 13.54% | NVD 3.925 -1.63% | WFF 0.0598 -33.41% | NU 12.42 -1.35% | SOXL 101.58 12.24% | EWZ 34.425 0.82% | SPCX 149.57809 1.82% | INTC 93.97 3.87% | BBD 2.935 0.34% | SOXS 42.23 -11.98% | GPUS 0.212 18.77% | JBLU 2.825 19.20% | NVDA 217.99 0.92% | SNTI 0.1769 1.03% | GRAB 2.72 0.37% | VALE 11.78 -1.83% | RCT 0.064 -22.61% | TSLL 11.645 8.22% | AAL 12.6396 3.60% | QID 13.825 -2.78% | NOK 8.925 3.70% | TSLG 5.83 8.36% | CRWV 59.5599 7.92% | TQQQ 71.3229 4.23% | BITO 10.755 0.94% | HYG 77.595 0.51% | BRAI 3.8401 81.14% | RWM 14.325 -1.21% | BA 167.535 -11.03% | STLA 4.0951 0.37% | ONDS 6.6501 7.96% | IREN 27.385 7.69% | TSLA 407.675 4.10% | CIFR 8.415 9.14% | META 621.77 -1.39% | PLUG 1.43 4.38% | XP 15.99 1.81% | NFLX 62.6211 -2.00% | SCHP 25.635 -0.02% | SQQQ 36.78 -4.17% | MEGL 0.2938 -58.97% | ITUB 7.7001 0.00% | KORU 11.91 9.37% | WULF 12.7123 6.11% | MARA 7.0893 3.64%
UBProShares UltraPro Nasdaq Biotechnology logo

ProShares UltraPro Nasdaq Biotechnology (UBIO)

NASDAQ Global Market · Currency in USD
$17.77 ▲ +0.00 (+0.00%)
At close: Mar 27, 3:59 PM ET. Market closed.

Summary

Previous Close
$17.77
Open
$17.97
Day's Range
$17.43 – $19.24
52 Week Range
$13.13 – $34.80
Volume
34,710
Avg. Volume
41,974
Market Cap
$15.09M
Beta (5Y Monthly)
3.15
PE Ratio (TTM)
--
EPS (TTM)
--
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: ProShares UltraPro Nasdaq Biotechnology

Sector
Financial Services
Industry
Asset Management - Leveraged
Full-time employees
--
CEO
--
Website
--

This fund aims to deliver daily returns equal to three times (3x) the daily movement of the NASDAQ Biotechnology Index, prior to accounting for fees and operating costs. To achieve this, it strategically deploys capital into various financial instruments, which ProShare Advisors expects will collectively mirror its ambitious daily performance target. The underlying index itself is a modified capitalization-weighted benchmark, comprising stocks of companies listed on Nasdaq that fall within the biotechnology or pharmaceutical sectors.

Earnings

No earnings history available.

Get free alerts on UBIO and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.